Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Making Strides

For a third year Duke Cancer Institute has teamed up with the American Cancer Society to serve as local presenting sponsor at the charity's 10th Annual Making Strides Against Breast Cancer walk. Last year’s event raised more than $289,000 to support the fight against breast cancer. This year,...

Kirsch Promoted

David G. Kirsch, MD, PhD, was recently promoted to Professor of Radiation Oncology and Professor of Pharmacology and Cancer Biology. Kirsch received his MD and PhD degrees in 2000 from Johns Hopkins University School of Medicine. He received his PhD in Cellular and Molecular Medicine. Then, Kirsch...

July Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list includes Nadine Barrett, PhD; Francis Ali-Osman, MD; Michael Kastan, MD, PhD; and many more.

Scientists Trace Origin Cell of Bone and Soft Tissue Tumors

Scientists at Duke Health are part of a team that has discovered a type of cell surrounding blood vessels can also serve as a starting point for sarcoma, a form of cancer that occurs in bones and connective tissues. The findings, made through studies of mice, offer insights that could aid in the...

Collaboration Focus at Cancer Moonshot Summit

As a part of Vice President Joe Biden’s Cancer Moonshot Summit in Washington, DC last month, leaders from North Carolina’s three comprehensive cancer centers gathered at the University of North Carolina at Chapel Hill to convene their own regional summit. “The goal of the ‘moonshot’ is to propel us...

Women with BRCA1 Gene Mutation at Higher Risk of Deadly Uterine Cancer

Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form of uterine cancer, according to a study led by a Duke Cancer Institute researcher. This newly defined risk -- the first to show a conclusive link...

Southern Pines Man Steps Out In Fight Against Breast Cancer

Joseph “Joe” Rasmus, 52, may not have breast cancer, but after losing his wife to cancer earlier this year and with his own battle with lipomas, Joe was compelled to step out June 11 for the local Komen Race For the Cure. “Since my diagnosis in 2008 I have had 24 lipomas removed—five of which were...

Willett To Receive 2016 ASTRO Gold Medal Award

Christopher Willett, MD, was one of three individuals recently named by the American Society for Radiation Oncology (ASTRO) to receive a Gold Medal Award, the highest honor given to select members of the world’s largest radiation oncology society. Willett, who in 1981 received his medical degree...

Hyslop Honored As New ASA Fellow

Terry Hyslop, PhD, has been named a Fellow of the American Statistical Association (ASA), the nation’s preeminent professional statistical society. Honorees are recognized for outstanding professional contributions to and leadership in the field of statistical science. The 2016 fellows will be...

Lace Up & Step Out

The 2016 Gail Parkins Memorial Ovarian Cancer Walk and 5K Run will take place Saturday, Sept. 17, at Sanderson High School, located at 5500 Dixon Drive in Raleigh, North Carolina. The event, which raises both awareness and funds for ovarian cancer research at Duke, features a 5K run and a 2-mile...

June Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list includes Arif Kamal, MD, MBA, MH; Thomas LeBlanc, MD, MA; Jason Locasale, PhD; and many more.

How Common Chemotherapy Drugs Work

A study by scientists at Duke Health is providing insight into how certain commonly-used chemotherapy drugs work, potentially opening new ways to enhance the benefits of treatment for cancer patients. The scientists focused on antimetabolites, chemotherapy drugs that target metabolism in cancer...

Pages